tradingkey.logo
tradingkey.logo
検索

Sonoma Pharmaceuticals Inc

SNOA
ウォッチリストに追加
1.210USD
0.0000.00%
終値 07/02, 13:00ET15分遅れの株価
2.09M時価総額
損失額直近12ヶ月PER

詳細情報 Sonoma Pharmaceuticals Inc 企業名

Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.

Sonoma Pharmaceuticals Incの企業情報

企業コードSNOA
会社名Sonoma Pharmaceuticals Inc
上場日Jan 26, 2007
最高経営責任者「CEO」Trombly (Amy)
従業員数168
証券種類Ordinary Share
決算期末Jan 26
本社所在地5445 Conestoga Court, Suite 150
都市BOULDER
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号80301
電話番号18007599305
ウェブサイトhttps://sonomapharma.com/
企業コードSNOA
上場日Jan 26, 2007
最高経営責任者「CEO」Trombly (Amy)

Sonoma Pharmaceuticals Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Jay E. Birnbaum, Ph.D.
Dr. Jay E. Birnbaum, Ph.D.
Independent Director
Independent Director
286.00
-0.35%
Mr. Jerry G. Mclaughlin
Mr. Jerry G. Mclaughlin
Lead Independent Director
Lead Independent Director
--
--
Mr. Philippe Weigerstorfer
Mr. Philippe Weigerstorfer
Independent Director
Independent Director
--
--
Ms. Amy Trombly
Ms. Amy Trombly
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jerry Dvonch
Mr. Jerry Dvonch
Chief Financial Officer
Chief Financial Officer
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Jay E. Birnbaum, Ph.D.
Dr. Jay E. Birnbaum, Ph.D.
Independent Director
Independent Director
286.00
-0.35%
Mr. Jerry G. Mclaughlin
Mr. Jerry G. Mclaughlin
Lead Independent Director
Lead Independent Director
--
--
Mr. Philippe Weigerstorfer
Mr. Philippe Weigerstorfer
Independent Director
Independent Director
--
--
Ms. Amy Trombly
Ms. Amy Trombly
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jerry Dvonch
Mr. Jerry Dvonch
Chief Financial Officer
Chief Financial Officer
--
--

よくある質問

Sonoma Pharmaceuticals Incの上位5名の株主は誰ですか?

Sonoma Pharmaceuticals Incの上位5名の株主は以下のとおりです。Dr. Jay E. Birnbaum, Ph.D.

Sonoma Pharmaceuticals Inc(SNOA)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Sonoma Pharmaceuticals Incの株式を保有している機関は40社あり、保有株式の総市場価値は約127.80Kで、全体の3.68%を占めています。2025Q4と比較して、機関の持ち株は-34692.00増加しています。

Sonoma Pharmaceuticals Incの最大の収益源は何ですか?

2026Q1において、Human Care部門がSonoma Pharmaceuticals Incにとって最大の収益を生み出しており、その金額は3.86Mで、全収益の88.83%を占めています。